Khattar Jack A.
CIK 1539937
Transactions on file
52
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-11-04 | 2026-11-02 | SUPN Supernus, Inc. | OfficerDirector Chief Executive Officer | Other | 1,475,569 | $0.00 | — | open → |
| 2026-11-04 | 2026-11-02 | SUPN Supernus, Inc. | OfficerDirector Chief Executive Officer | Other | 1,937,986 | $0.00 | — | open → |
| 2026-11-04 | 2026-11-02 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Other | 958,100 | $0.00 | — | open → |
| 2026-11-04 | 2026-11-02 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Other | 1,258,351 | $0.00 | — | open → |
| 2026-08-14 | 2026-08-12 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Tax | 12,642 | $588.7K | -39.6% | open → |
| 2026-08-14 | 2026-08-12 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Exer. | 29,849 | $0.00 | — | open → |
| 2026-06-22 | 2026-06-17 | CGTX COGNITION THERAPEUTICS INC | Director | Grant | 25,000 | $0.00 | — | open → |
| 2025-03-07 | 2025-03-07 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Tax | 18,581 | $726.7K | -28.0% | open → |
| 2025-03-07 | 2025-03-07 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Exer. | 38,640 | $0.00 | — | open → |
| 2025-03-11 | 2025-03-10 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Tax | 16,805 | $538.8K | -12.2% | open → |
| 2025-03-11 | 2025-03-10 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Exer. | 35,000 | $0.00 | — | open → |
| 2025-04-03 | 2025-04-02 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Other | 16,850 | — | — | open → |
| 2025-04-03 | 2025-04-02 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Other | 16,850 | — | — | open → |
| 2025-06-23 | 2025-06-18 | CGTX COGNITION THERAPEUTICS INC | Director | Grant | 34,000 | $0.00 | — | open → |
| 2025-10-10 | 2025-10-09 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Sale | 1,529 | $78.7K | -45.3% | open → |
| 2025-10-10 | 2025-10-09 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Sale | 58,371 | $2.95M | -44.3% | open → |
| 2025-10-10 | 2025-10-09 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Exer. | 81,250 | $2.06M | +11.3% | open → |
| 2025-10-03 | 2025-10-02 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Tax | 7,529 | $347.9K | -39.1% | open → |
| 2025-10-03 | 2025-10-02 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Exer. | 19,320 | $0.00 | — | open → |
| 2025-10-03 | 2025-10-02 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Tax | 7,796 | $360.3K | -39.1% | open → |
| 2025-10-03 | 2025-10-02 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Exer. | 20,000 | $0.00 | — | open → |
| 2025-10-03 | 2025-10-02 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Sale | 1,904 | $91.5K | -41.4% | open → |
| 2025-10-03 | 2025-10-02 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Exer. | 2,267 | $57.4K | +11.3% | open → |
| 2025-10-02 | 2025-10-01 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Sale | 40,173 | $1.93M | -41.4% | open → |
| 2025-10-02 | 2025-10-01 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Exer. | 53,785 | $1.36M | +11.3% | open → |
| 2025-10-01 | 2025-09-30 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Sale | 8,588 | $414.4K | -41.7% | open → |
| 2025-10-01 | 2025-09-30 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Exer. | 11,510 | $291.2K | +11.3% | open → |
| 2025-10-07 | 2025-10-07 | SCPH scPharmaceuticals Inc. | U | 5,000 | $0.00 | — | open → | |
| 2025-08-08 | 2025-08-06 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Sale | 38,500 | $1.55M | -30.0% | open → |
| 2025-08-08 | 2025-08-06 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Sale | 38,000 | $1.60M | -33.0% | open → |
| 2025-08-08 | 2025-08-06 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Exer. | 81,250 | $2.06M | +11.3% | open → |
| 2025-08-08 | 2025-08-06 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Sale | 63,500 | $2.74M | -34.7% | open → |
| 2025-08-08 | 2025-08-06 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Exer. | 60,000 | $778.8K | +116.9% | open → |
| 2025-08-08 | 2025-08-06 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Exer. | 60,000 | $778.8K | +116.9% | open → |
| 2025-08-26 | 2025-08-22 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Sale | 1,500 | $67.5K | -37.4% | open → |
| 2025-08-26 | 2025-08-22 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Exer. | 2,415 | $31.3K | +116.9% | open → |
| 2025-08-27 | 2025-08-25 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Exer. | 1,611 | $20.9K | +116.9% | open → |
| 2025-08-27 | 2025-08-25 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Sale | 1,000 | $45.0K | -37.4% | open → |
| 2025-08-29 | 2025-08-28 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Sale | 24,150 | $1.09M | -37.6% | open → |
| 2025-08-29 | 2025-08-27 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Exer. | 17,195 | $223.2K | +116.9% | open → |
| 2025-08-29 | 2025-08-27 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Sale | 10,650 | $479.8K | -37.5% | open → |
| 2025-08-29 | 2025-08-28 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Exer. | 38,779 | $503.4K | +116.9% | open → |
| 2025-09-08 | 2025-09-05 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Sale | 55,578 | $2.56M | -38.8% | open → |
| 2025-09-08 | 2025-09-05 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Exer. | 73,176 | $1.85M | +11.3% | open → |
| 2025-09-09 | 2025-09-08 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Exer. | 8,074 | $204.3K | +11.3% | open → |
| 2025-09-09 | 2025-09-08 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Sale | 6,322 | $292.6K | -39.2% | open → |
| 2025-09-23 | 2025-09-22 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Sale | 16,587 | $779.9K | -40.1% | open → |
| 2025-09-23 | 2025-09-22 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Exer. | 27,060 | $351.2K | +116.9% | open → |
| 2025-09-24 | 2025-09-23 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Exer. | 47,940 | $622.3K | +116.9% | open → |
| 2025-09-24 | 2025-09-23 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Sale | 29,513 | $1.39M | -40.4% | open → |
| 2025-09-30 | 2025-09-29 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Sale | 10,235 | $491.5K | -41.4% | open → |
| 2025-09-30 | 2025-09-29 | SUPN SUPERNUS PHARMACEUTICALS, INC. | OfficerDirector President, CEO | Exer. | 13,688 | $346.3K | +11.3% | open → |
